Oscar Health, Inc. (NYSE:OSCR) Stock Position Raised by Algert Global LLC

Algert Global LLC raised its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 63.3% in the third quarter, Holdings Channel reports. The firm owned 369,685 shares of the company’s stock after buying an additional 143,346 shares during the period. Algert Global LLC’s holdings in Oscar Health were worth $7,841,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC raised its stake in shares of Oscar Health by 7.5% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock valued at $255,000 after acquiring an additional 844 shares in the last quarter. American International Group Inc. raised its stake in shares of Oscar Health by 1.3% in the 1st quarter. American International Group Inc. now owns 79,411 shares of the company’s stock valued at $1,181,000 after acquiring an additional 1,009 shares in the last quarter. Summit Trail Advisors LLC raised its stake in shares of Oscar Health by 5.4% in the 2nd quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company’s stock valued at $329,000 after acquiring an additional 1,065 shares in the last quarter. KBC Group NV raised its stake in shares of Oscar Health by 41.2% in the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after acquiring an additional 1,328 shares in the last quarter. Finally, Arizona State Retirement System raised its stake in shares of Oscar Health by 3.7% in the 2nd quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock valued at $602,000 after acquiring an additional 1,351 shares in the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $15.98 on Friday. Oscar Health, Inc. has a 1-year low of $7.29 and a 1-year high of $23.79. The firm has a market capitalization of $3.95 billion, a PE ratio of -266.33 and a beta of 1.67. The business’s 50 day moving average is $17.90 and its 200-day moving average is $18.20. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. During the same period in the previous year, the business posted ($0.29) EPS. Oscar Health’s revenue for the quarter was up 68.3% compared to the same quarter last year. Sell-side analysts predict that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Piper Sandler reissued an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a research note on Tuesday, September 10th. Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, UBS Group started coverage on Oscar Health in a report on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price on the stock. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Oscar Health presently has a consensus rating of “Moderate Buy” and an average price target of $22.93.

Insider Transactions at Oscar Health

In related news, insider Mario Schlosser sold 3,198 shares of the business’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the sale, the insider now owns 76,982 shares of the company’s stock, valued at $1,384,906.18. The trade was a 3.99 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Victoria Baltrus sold 4,226 shares of the business’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $76,025.74. Following the completion of the sale, the chief accounting officer now directly owns 140,648 shares in the company, valued at approximately $2,530,257.52. This represents a 2.92 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have bought 1,055,478 shares of company stock valued at $14,432,852 and have sold 194,569 shares valued at $3,433,319. 25.11% of the stock is owned by insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.